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Abstract
The antibody response in serum and the reproductive tract of female rabbits to a model antigen, influenza virus haemagglutinin (HA),
encoded by a recombinant myxoma virus was investigated. Strong and lasting IgG antibody responses to HA were induced in serum
following intradermal, intranasal, and intravaginal immunisations. HA IgG was also detected in reproductive tract fluids but was only about
1% the titer of that in serum. HA IgA was not detected in serum of any infected groups and was occasionally detected in reproductive tract
fluids at a low titer only after infections through mucosal sites. HA IgM was also detected only in some of the reproductive tract fluids at
very low levels. Induction of ovulation did not change these patterns and B cell homing to the reproductive tract was not profound. In
contrast, HA IgG and IgM titers in ovarian follicular fluids were comparable to that in serum. These data suggest that if this virus is used
to deliver an immunocontraceptive vaccine that requires a high-level antibody response, the target antigen needs to be accessible to serum
antibody or in the ovary.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The European rabbit (Oryctolagus cuniculus) is an intro-
duced vertebrate pest species in Australia, causing signifi-
cant losses in agricultural production and severe environ-
mental degradation (Holland and Jackson, 1994). The
current methods to control the rabbit population are basi-
cally lethal, including trapping, poisoning, shooting, and
inducing viral diseases. These methods have disadvantages;
some are costly; some are non-species-specific; and all have
been met with only partial success (Holland and Jackson,
1994). In the meantime, the lethal methods are considered
inhumane by the public (Tyndale-Biscoe, 1994). As an
alternative, fertility control was suggested since it was be-
lieved to have significant advantages over lethal methods in
controlling high-fertility animals such as the European rab-
bit (Bradley, 1994). To achieve this, a biological approach
of fertility control by developing a myxoma virus vectored
immunocontraceptive vaccine was proposed (Tyndale-
Biscoe, 1994; Holland and Jackson, 1994). It is believed
that this vaccine will be species-specific, cheap, and long
lasting in rabbits because it is vectored by a live and rabbit-
specific virus, the myxoma virus (Holland and Jackson,
1994).
Although antigen genes from both gametes can be vec-
tored for the immunocontraceptive vaccine according to the
proposal of fertility control, targeting at sperm antigens has
advantages of being a foreign protein to the females and a
strong immune response would be induced (Holland and
Jackson, 1994). A previous study in rabbits showed that
antibodies to sperm antigen in the reproductive tract fluids
played the major role in blocking fertilisation (Menge and
Lieberman, 1974). The Fab fragment of antibody to a rabbit
sperm antigen (termed RSA) could also bind to the post-
acrosomal region of the sperm and inhibit sperm–zona bind-
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ing and penetration both in vitro and in vivo (O’Rand et al.,
1988). Monoclonal antibodies to rabbit sperm protein
epitopes were also raised and were shown to be able to
block fertilisation in vitro (Holland and Jackson, 1994).
These data suggest that antibody to specific sperm proteins
can effectively inhibit fertilisation by blocking the interac-
tion with oocytes. Therefore, the ability of recombinant
myxoma virus to induce a strong and lasting antibody re-
sponse in the female reproductive tract to the sperm antigen
is essential for such a strategy to be a success.
As other poxviruses, myxoma virus has been genetically
modified to express foreign genes and induce antibody re-
sponses (Kerr and Jackson, 1995; Jackson et al., 1996;
Bertagnoli et al., 1996). Female rabbits intradermally in-
fected with a recombinant myxoma virus expressing influ-
enza HA produced a high and sustained IgG response to HA
in blood plasma and a detectable level of IgG antibody in
vaginal washings (Kerr and Jackson, 1995). The results
support the view that the virus can be explored as a candi-
date for delivering immunocontraceptive vaccine. However,
to date, no studies on whether a high-level IgG or an IgA
antibody response could be induced in the whole reproduc-
tive tract, including the uterus and oviduct, have been re-
ported.
The female reproductive tract is considered as a part of
the common mucosal immune system (McGhee et al.,
1999). Distal immunisations, such as intranasal immunisa-
tion, with a recombinant adenovirus expressing HSV-1 gly-
coprotein B induced specific IgG and IgA responses in
serum and vaginal secretions (Gallichan et al., 1993; Gal-
lichan and Rosenthal, 1995). Antibody-secreting cells
(ASC) were also found to home back to the reproductive
tract after immunisation with this recombinant virus (Gal-
lichan and Rosenthal, 1998). Moreover, local immunisa-
tions through vaginal surface were shown to be able to
induce local mucosal antibody responses in the genital tract
of mice (Johansson et al., 1998) and human (Kozlowski et
al., 1999). In rabbits, a detectable IgA antibody response
was induced in reproductive tract secretions after intravag-
inal immunisation and repeated boosters with horseradish
peroxidase (McAnulty and Morton, 1978). Therefore, it is
of interest to investigate if a replicating antigen delivered by
a recombinant myxoma virus could enhance antibody re-
sponses in the female rabbit reproductive tract by distal or
local immunisations.
In rats and mice, the antibody titres of IgG and IgA in
reproductive tract secretions varied with the concentration
changes of the oestrogen and progesterone in blood during
the oestrous cycles (Wira and Sandoe, 1980; Wira and
Sullivan, 1981; Sullivan and Wira, 1984; Wira and Sandoe,
1987; Wang et al., 1996; Gallichan and Rosenthal, 1996).
Unlike rodents, which exhibit regular oestrous cycles, the
rabbit is an induced ovulator with oestrogen being the dom-
inant ovarian hormone until mating occurs (Hammond and
Marshall, 1925). It was unclear how this would affect the
immune response in the reproductive tract.
On the other hand, if an ovarian antigen gene, encoding
a sperm receptor protein, is vectored for immunocontracep-
tion in females, the antibodies in serum or the ovary are
important because serum antibody levels to the zona pellu-
cida protein (ZP) were directly correlated to the infertility
rate in mice (Jackson et al., 1998) and rabbits (Kerr et al.,
1999). Antibodies to ZP in the ovary could also bind to ZP
of oocytes and cause disruption of both oocytes and follicles
(Jackson et al., 1998; Kerr et al., 1999; Skinner et al., 1984).
However, it is not clear whether a strong antibody response
induced in serum by a recombinant myxoma virus could
equalise to the rabbit ovary.
The answers to the questions mentioned above are very
important in determining which reproductive antigen to be
used and whether strategies of immunocontraception that
require high levels of antibody in the reproductive tract can
be developed. In the present study, a model strong antigen,
influenza HA encoded by a recombinant myxoma virus, was
used to investigate the use of a live viral vector as a means
of inducing an immune response in the female rabbit repro-
ductive tract both before and after ovulation. The efficiency
of intradermal, intravaginal, and intranasal routes of infec-
tive immunisation was compared. The specific antibody
titres in ovarian follicular fluids were also determined.
Results
Antibody response to HA following intradermal infection
and the effect of ovulation on antibody titres
A strong IgG antibody response to influenza HA was
detected in serum at both 15 and 30 days after intradermal
infection with recombinant myxoma virus expressing influ-
enza virus haemagglutinin (MV-HA) (Fig. 1). HA IgG was
also detectable in the reproductive tract fluid collected by
either flushing or micropuncture methods, but the titres
were 100 to 1000-fold lower than those in serum (Fig. 1).
No differences of IgG antibody titres were found in the fluid
samples obtained from different regions of the reproductive
tract (Fig. 1). HA-specific IgM in serum was 2.68  0.38
(mean log10  SD) at 15 days and 2.22  0.28 at 30 days
postinfection. However it was detected in only one oviduc-
tal flushing at a titre of 1/5 and two micropuncture samples
at the same titres. HA-specific IgA was not detectable in any
serum or reproductive tract fluid samples from any infected
rabbits. Similarly, HA IgG, IgM, and IgA were not detected
in serum and reproductive tract fluids from uninfected con-
trols.
There was no remarkable difference of HA IgG titres
between reproductive tract flushing and micropuncture sam-
ples (Fig. 1). However, the micropuncture samples were
collected from free-flowing fluids in the lumen of the re-
productive tract (volume of 100–150 l), whereas the flush-
287W. Gu et al. / Virology 313 (2003) 286–295
ing samples were collected by flushing the lumen with 1 ml
PBS. Therefore, compared with micropuncture samples, the
flushing samples were diluted about 10 times. However, this
did not affect HA IgG titres in flushing samples, suggesting
that the flushings may contain some components that have a
higher level of HA IgG than in the free fluids. Mucus at the
lumen surface of the tract is the most likely source of this
HA IgG. Nevertheless, this result suggests that IgG anti-
body titres in the flushing samples are representative of the
IgG antibody titres in the reproductive tract free fluids.
Induction of ovulation did not significantly affect HA
IgG titres in serum and reproductive tract fluids at either 15
or 30 days postinfection. The titres in serum were still high
and those in the reproductive tract fluids remained low at
both time points (Fig. 1). Again, no remarkable differences
of HA IgG titres were found between samples collected by
flushing and micropuncture methods. Similarly, titres from
different regions of the reproductive tract were comparative
(Fig. 1). HA-specific IgM titres in serum of human chori-
onic gonadotrophin (hCG)-treated rabbits were 2.7  0.45
for 15 days and 2.15  0.17 for 30 days postinfection. HA
IgM was detected in only one oviductal, uterine, and vaginal
flushings from a single rabbit at the titres of 1:10, 1:10, and
1:40, respectively. These values are similar to those obtained
prior to ovulation. HA IgM was not detected in micropuncture
samples, serum, and reproductive tract flushings from unin-
fected controls after induction of ovulation. HA-specific IgA
was also not detectable in any serum or reproductive tract fluid
samples collected from hCG-treated rabbits.
Antibody response to HA and the virus following mucosal
immunisations
To be able to provoke a strong antibody response includ-
ing a specific IgA response in the reproductive tract, intra-
nasal and intravaginal immunisations were conducted. Sim-
ilar to intradermal infection, both immunisations induced a
strong HA IgG antibody response in serum with a much
lower IgG antibody titre in reproductive tract flushings at
either 15 or 30 days postimmunisations (Fig. 2). HA IgA
titres were measured in four oviductal and one uterine
flushings at a titre of 1/3 from the intranasal group. For the
intravaginal group, it was detected only in one oviductal and
one uterine flushings at a titre of 1/3. Compared with intra-
vaginal route, intranasal immunisation elicited a higher (P
 0.05) HA IgG titre in serum at both time points. These
titres were also higher than those from the intradermal
Fig. 1. HA-specific IgG titres in serum and reproductive tract fluids following intradermal immunisation with MV-HA. Female rabbits (n 16) were infected
with 1  106 PFU MV-HA and treated with hCG or untreated before sampling. Specific IgG titre to influenza HA was determined in serum and fluids
collected from oviduct, uterus, and vagina by both flushing (four rabbits) and micropuncture (two rabbits) at either 15 or 30 days postinfection. The titres
were expressed as mean log10 titres of four samples for flushings and of two samples for micropunctures. The error bars represent SD and were calculated
only for flushing samples. M: micropuncture; F: flushing.
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group (P  0.01 for both). Correspondingly, in the repro-
ductive tract fluids, higher HA IgG titres were detected in
oviduct and vagina (P  0.05 for both) at 30 days postin-
fection for the intranasal group than the intravaginal group.
HA-specific IgM in serum was 3.05 0.17 and 1.93 0.15
for the intranasal group at 15 and 30 days postinfection and
was 2.6  0.48 and 1.78  0.28 for the intravaginal group
at 15 and 30 days postinfection. However HA IgM was
detected in only one uterine flushing at a titre of 1/5 in the
intranasal group and two oviductal flushings at the same
titre in the intravaginal group.
Specific IgG and IgA antibody responses to the vector,
myxoma virus, were also measured in sera and reproductive
tract fluids from mucosal groups. Similar to HA, specific IgG
titres to myxoma virus were high in serum and much lower in
reproductive tract flushings (Table 1). No specific IgA to MV
was detectable in either serum or reproductive tract samples.
General IgG titers in serum and reproductive tract fluids
Similar to specific IgG, general IgG titres in serum were
about 100-fold higher than that in reproductive tract fluids
for all groups (Table 2). Induction of ovulation did not
significantly change general IgG titres in either serum or
reproductive tract fluids. Similarly, no significant differ-
ences were found between samples collected from different
regions of the reproductive tract for both intradermal and
control groups (Table 2). However, in mucosal immunised
groups, the mean IgG titres in oviductal fluids were higher
than those in uterus (P  0.01 for both I.n and I.va.) and
vagina (P  0.001 for I.n and P  0.05 for I.va, Table 2).
For all the infected groups, the ratio of HA-specific IgG to
general IgG titres in serum was similar to or no less than
those obtained in the reproductive tract fluids. This suggests
that the specific IgG present in the reproductive tract fluids
might mainly derive from serum transudation but not from
local production.
Table 1
MV specific IgG titres in serum and reproductive tract flushings after
mucosal immunisations with MV-HA
Route Time point Serum Oviduct Uterus Vagina
I.n. D15 4.1, 4.1 1.4, 1.1 1.4, 1.1 1.1, 0
D30 4.7, 4.7 2.9, 2.9 2.0, 2.0 2.0, 1.1
I.va. D15 3.2, 2.6 1.7, 0 1.1, 0 0, 0
D30 4.1, 3.5 1.7, 1.1 1.4, 0 0, 0
Note. The values are log10 titres. I.n.: intranasal group; I.va.: intravag-
inal group.
Fig. 2. HA-specific IgG in serum and reproductive tract fluids following mucosal immunisations with MV-HA. Female rabbits (n  16) were intranasally
or intravaginally immunised with 1  106 PFU MV-HA. Specific IgG titres to influenza HA were measured in serum and flushing samples from the oviduct,
uterus, and vagina at 15 and 30 days postinfection. The antibody titres were expressed as mean log10 titres for four samples. The error bars represent SD.
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Time course of mucosal antibody response in vaginal
washings
To investigate if HA IgA titre peaks over 30 days after
mucosal immunisation, HA IgA and IgG titres were moni-
tored in serum and vaginal washing until 70 days after
intravaginal or intranasal immunisations and at 3, 6, and 10
days after intravaginal boost with influenza virus (HA). HA
IgA was still not detectable in either serum or washing
samples and HA IgG titres in vaginal washings were much
lower than that in serum but the titres were in parallel with
those in serum and remained elevated similarly to the serum
titres (Fig. 3). After boosting, although the antibody levels
were elevated slightly, the expected range in HA IgG titres
were not obtained (Fig. 3). No HA IgG or IgA was detected
in preimmune serum and vaginal washings.
Replication of recombinant virus in the reproductive tract
and B cell homing
Intranasal and intravaginal immunisations with MV-HA
resulted in local replication of the recombinant virus. Tears
and red eyes were observed in seven of the eight intrana-
sally immunised rabbits and red and swollen vaginas were
observed in six of eight intravaginally immunised rabbits
between days 10 and 20 postinfection. To verify viral rep-
lication, frozen sections of reproductive tract tissues were
probed with anti-MV monoclonal antibody (clone 3B6E4,
to a 42-kDa protein produced in the late infection) (Fountain
et al., 1997) to detect myxoma virus. Viral-positive cells
were found in the epithelium or subepithelium of the vagina
and cervix from rabbits at both 15 and 30 days postinfection
(Fig. 4). HA-positive cells were also detected in the tissue
sections after probing with rat anti-HA sera and these pos-
itive cells located in the similar areas to MV-positive cells,
indicating that HA was expressed in the viral infected cells
(Fig. 4). Double labelling the viral-positive cells in the
vagina and cervix with monoclonal antibodies to MV and
rabbit MHC class II showed that most of the viral-positive
cells were also MHC class II positive (Fig. 4).
The replication of recombinant myxoma virus in MHC
class II positive cells of the reproductive tract and the IgG
antibody response to HA after intravaginal immunisation
suggested that antigen presentation in the tract must had
occurred probably in the local draining lymph nodes of the
Table 2
General IgG titers in serum and reproductive tract fluids
Groups Serum Flushing Micropuncture
OD UT VAG OD UT VAG
Control 4.86 0.17 2.53  0.28 2.68  0.28 2.12  0.33 nd nd nd
HCG 4.78  0.15 2.68  0.28 2.53  0.37 2.35  0.7 2.75 2.75 3.05
I.d.
15D 4.78  0.28 2.45  0.38 2.3  0.65 2.29 0.49 2.3 2.3 2.15
30D 4.78  0.15 2.53  0.62 2.6  0.42 2.22 0.51 2.45 2.75 2.9
I.d. H
15D 5.0  0.3a 2.38 0.28 2.53  0.28 2.37  0.62 3.2a 2.9a 2.75
30D 4.94  0.28 2.83  0.37 2.3  0.42 2.15 0.39 2.15 2.75 2.75
I.n.
15D 5.23  0.28 2.75  0.39 2.6  0.35 2.38 0.38 nd nd nd
30D 5.15  0.17 2.83  0.15 1.68  0.53 1.85  0.17 nd nd nd
I.va.
15D 4.93  0.15 3.13  0.29 2.08  0.38 2.0  0.69 nd nd nd
30D 5.0  0.24 2.23 0.51 1.08  1.29b 0.78  0.9b nd nd nd
Note. The values represent mean log10 titers  SD from four rabbits for flushing samples and from two rabbits for micropuncture samples. OD: oviduct;
UT: uterus; VAG: vagina; I.d.: intradermal infection; D: days postinfection; H: infection with induced ovulation; I.n.: intranasal immunisation; I.va.:
intravaginal immunisation. a: one sample missing; b: no IgG was detected in some samples; nd: not detected.
Fig. 3. HA-specific IgG in serum and vaginal washings after mucosal
infection with MV- HA and boost with HA. Female rabbits (n  4) were
intranasally or intravaginally immunised with 1  106 PFU MV-HA and
were intravaginally boosted (arrow) with 5000 HA units influenza virus 70
days later. HA-specific IgG titres were determined in serum and vaginal
washings collected at days 3, 15, 30, 45, 70 postinfection and days 3, 6, 10
postboosting. The antibody titres were expressed as mean log10 titres of
two rabbits.
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tract (McGhee et al., 1994, 1999). If this was true, B cell
homing to the reproductive tract (IgA plasma cell increase)
should be detected in reproductive tract tissues (McGhee et
al., 1994). To test this, IgA-positive cells were labelled in
frozen tissue sections of the oviduct, uterus, cervix, and
vagina. Compared with uninfected controls, no considerable
increase of IgA-positive (plasma) cells were seen in these
tissues from most intravaginally infected rabbits. However,
more IgA plasma cells were found in the uterus from a few
infected rabbits.
HA antibodies in ovarian follicular fluids
HA IgG and IgM titers were measured in ovarian follic-
ular fluids of four intradermally infected female rabbits. The
mean titre of HA IgG in ovarian follicular fluids was exactly
the same as in serum (both were 4.85  0.17, Fig. 5). HA
IgM titre in ovarian follicular fluids was also comparable to
that in serum (Fig. 5). No HA IgG or IgM was detected in
preimmune serum.
Discussion
The current data confirm the previous study (Kerr and
Jackson, 1995), showing that recombinant myxoma virus
was effective at inducing a strong serum antibody response
to HA in rabbits. Strong and lasting serum IgG antibody
responses were also demonstrated following intranasal and
intravaginal immunisations. A previous study showed that
an inoculation of as little as 5 PFU of the recombinant
myxoma virus was sufficient to infect the rabbit and induce
an antibody response to HA. The recombinant myxoma
virus was also remarkably attenuated compared with the
parental Uriarra strain after the insert of HA cDNA (Kerr
and Jackson, 1995). Only local inflammatory responses
were observed after high dose (106 PFU) mucosal admin-
istrations in the current study. Kerr and Jackson (1995)
explained the probable reasons for the attenuation of the
recombinant virus. First, a single basepair of the viral TK
gene was deleted during the construction of the transfection
plasmid pUrTK11/HA, which resulted in the TK gene con-
taining eight extra codons at its 3 end. This alteration may
cause the attenuation of the recombinant virus. Second, the
repeated selection of recombinant virus by plaque purifica-
tion may have selected a more attenuated virus. Finally, the
expression of HA attenuated the virus in an unknown way.
Therefore, the recombinant myxoma virus can be used as an
effective and safe vector for delivering rabbit vaccines. In
practice, Bertagnoli et al. (1996) observed that recombinant
myxoma virus could encode a capsid protein of rabbit hem-
orrhagic disease virus and induced a protective immune
response to this disease (Bertagnoli et al., 1996).
Despite the strong IgG antibody response in serum, none
of the immunization routes in the current study was proven
to be effective in increasing IgG antibody concentration in
reproductive tract fluids. The IgG antibody in reproductive
tract fluids was mainly derived from serum as suggested by
the ratios of specific/general IgG in serum being similar to
that in reproductive tract fluids. Obviously, however, serum
IgG antibody did not efficiently transfer into reproductive
tract fluids; only about 1% IgG antibody or general IgG of
serum level was detected in the fluids. In addition, induction
of ovulation did not significantly alter specific and general
IgG levels in reproductive tract fluids. In contrast to rabbits,
in mice, IgG antibody titres in vaginal washings were more
than 10% of that in serum following immunization with
Fig. 5. Comparison of HA IgG and IgM antibody titres in serum and
ovarian follicular fluids. Female rabbits (n  4) were intradermally in-
fected with 1 106 PFU MV-HA. Specific antibody titres to influenza HA
of both IgG and IgM classes were measured in serum and ovarian follicle
fluids (ovary-ff) at 15 days postinfection. The antibody titres were ex-
pressed as mean log10 titres for four rabbits. The error bars stand for SD.
Fig. 4. MV, HA, and MHC class II positive cells in the lower reproductive
tract of female rabbits intravaginally immunised with MV-HA. Intravagi-
nal infection of female rabbits with MV-HA resulted in local replication of
the recombinant virus in the epithelium of the vagina (A). The positive
cells were mainly located at the basal region of epithelial cells (A, arrow).
Similar to viral-positive cells, HA-positive cells were also seen at the basal
region of the epithelium in the vagina (B, arrow). Double labelling the cells
in vagina with anti-MV (C1) and rabbit MHC class II (C2) monoclonal
antibodies showed that most MV-positive cells were also MHC-II-positive
(C1 and C2). However, the viral positive cells were not found in the vagina
(D) from intranasally infected rabbits. Ep: epithelium; Lu: lumen.
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recombinant adenovirus expressing HSV-1 (Gallichan and
Rosenthal, 1995). Furthermore, in mice, HSV-1-specific
IgG levels in vaginal washings varied depending on the
stage of the reproductive cycle with antibody levels being
significantly higher at dioestrous stage or after progesterone
administration than at the oestrous stage (Gallichan and
Rosenthal, 1996). These differences between rabbits and
mice may reflect the variation between species on IgG
transfer in the reproductive tract but may also reflect the
difference in endocrine status, in which rabbits differ dra-
matically from them in association with the induced ovula-
tion. The low levels of IgG antibody in reproductive tract
fluids were also reported in some previous studies in rabbits
following immunizations with sperm protein LDH-4 (Kille
and Goldberg, 1979) or alcohol dehydrogenase (Shapiro et
al., 1971). These results further support the above conclu-
sion. Although in the current study IgG antibody was shown
to be more concentrated in the mucus or at the surface of
luminal epithelium, its role in inhibiting fertilization needs
to be verified.
Compared with the recombinant adenovirus in the mouse
model, recombinant myxoma virus is less efficient at induc-
ing IgA antibody responses in rabbits. As shown in the
current study, mucosal immunisations with MV-HA re-
sulted in the local replication of recombinant virus. Partic-
ularly, after intravaginal administration, the virus replicated
in MHC class II positive cells, suggesting that antigen
presentation could have happened in the draining lymph
modes of the reproductive tract (McGhee et al., 1994,
1999). This was also supported by the strong IgG antibody
response in serum with some, albeit low, specific IgG titres
in reproductive tract fluids. However, there was no specific
IgA in serum and only trace amounts of HA IgA were
detected occasionally in reproductive tract fluids. In the
reproductive tract, although more IgA plasma cells were
present in some of the uterine mucosa, possibly reflecting
local specific IgA production however, this response was
not common and not accompanied by any increases in
general IgA titres in the reproductive tract fluids (data not
shown). Intravaginal boost with influenza virus (HA) also
failed to enhance specific IgA production in vaginal wash-
ings, suggesting that B cell homing was not profound.
Intranasal immunisation of rabbits with MV-HA and boost
resulted in a similar result. In contrast, in mice, intranasal
immunisation with a recombinant adenovirus which also
replicates in the airway induced a specific IgA response in
serum and specific IgG and IgA in vaginal secretions to
either HSV-1 glycoprotein B (Gallichan et al., 1993; Gal-
lichan and Rosenthal, 1995) or rabies virus glycoprotein
(Xiang and Ertl, 1999). HSV-1 antibody-secreting cells
were also found in the reproductive tract tissues after intra-
nasal or intravaginal immunisations with this recombinant
virus (Gallichan and Rosenthal, 1998). Gallichan and
Rosenthal (1995) showed that HSV-1-specific IgA in vag-
inal secretions of mice peaked at 34 days postinfection with
the recombinant adenovirus (Gallichan and Rosenthal,
1995). By contrast, in the current study, no specific IgA was
detected in rabbit vaginal washings within 70 days follow-
ing mucosal infections with MV-HA. However, in rabbits,
previous studies have shown that IgA antibody responses
can be induced in vaginal secretions by various antigens
(Menge and Lieberman, 1974; Winchell et al., 1997, 1998;
Schreckenberger et al., 2000), suggesting that rabbits are
capable of mounting IgA antibody responses. Therefore, the
low IgA antibody response in the current study could relate
to the myxoma virus infection itself. It is known that cells
infected with myxoma virus can produce cytokine receptor
(such as IFN- and TNF-) homologues (Nash et al., 1999).
The virus could also replicate in CD4 T cells and degrade
CD4 molecules (Barry et al., 1995). It is possible that such
effects could interfere with the cytokine network and then
the production of Th2 cytokines such as IL-4, 5, and 6, thus
suppressing IgA isotype switching and IgA production
(Husband et al., 1994, 1999; Strober and Ehrhardt, 1994).
But how this could happen is still unclear. In rabbits again,
induction of ovulation did not significantly change specific
or general (data not shown) IgA titres in reproductive tract
fluids. In contrast, in mice, specific IgA levels were varied
with ovarian hormone concentrations and were higher at
oestrus than at other stages of the cycle (Wang et al., 1996).
The difference once again suggests that the oestrogen-dom-
inated reproductive tract of rabbits may also influence IgA
secretion.
The collective data above suggest that a high-level
IgG and IgA antibody response cannot be easily achieved
in the female rabbit reproductive tract with the recombi-
nant virus delivery system. It is therefore not a suitable
vector to deliver antigens within the mucosal part of the
tract such as sperm proteins for immunocontraception.
However, the current study shows that the high levels of
IgG and IgM antibodies can be achieved in ovarian fol-
licular fluids. This indicates that the ovary is more ac-
cessible to serum antibodies and more suitable as a target
for immunocontraception than the mucosal part of the
reproductive tract. Previous data in rabbits showed that
general IgG concentration (Symons and Herbert, 1971) or
specific IgG titres to sperm protein LDH-4 (Kille and
Goldberg, 1979) in serum was comparable to those in
ovarian follicle fluids, supporting this view. The fact that
the recombinant virus can constantly induce a strong
antibody response in serum and the antibody can freely
access the ovary indicates that recombinant myxoma vi-
rus could be used as an effective vector to deliver ovarian
antigens for immunocontraception. Previous studies
showed that female rabbits immunised with porcine ZP
protein (Skinner et al., 1984) or recombinant rabbit ZPB
protein (Kerr et al., 1999) resulted in high infertility
rates. IgG antibody to ZP was also suggested as an
important contributor to the resultant infertility (Skinner
et al., 1984; Kerr et al., 1999). In addition, immunisation
of female rabbits with rabbit ZPB encoded by a recom-
binant virus resulted in 25% infertility (Kerr et al., 1999).
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These data support the finding that recombinant myxoma
virus can be used as a vector to deliver either heteroge-
neous or homogenous ovarian antigens for rabbit immu-
nocontraception.
Material and methods
Recombinant myxoma virus and viral antigens
The recombinant myxoma virus expressing influenza vi-
rus haemagglutinin under the control of the vaccinia virus
P11 late promoter was described previously (Kerr and Jack-
son, 1995). The HA gene was inserted into an intergenic site
of myxoma virus genome between thymidine kinase (TK)
and ORF MF8a (Kerr and Jackson, 1995; Jackson and
Bults, 1992). The recombinant virus is highly attenuated
after HA insert, causing few or no clinical signs of disease
apart from a swelling at the inoculation site (Kerr and
Jackson, 1995).
A preparation of whole influenza virus (strain A/PR/8/
34; kindly provided by Dr. Sonja Best, CSIRO Wildlife and
Ecology) was used to measure specific IgG, IgM, and IgA to
influenza HA in serum and reproductive tract fluids or
ovarian follicular fluids. This preparation was also used for
intravaginal boosting. The antigen used for measuring MV-
specific antibodies was a preparation of whole myxoma
virus (strain Lausanne, kindly provided by Louise Silvers,
CSIRO Wildlife and Ecology).
Animal, immunisation protocols, and collection of
samples
Mature female New Zealand White rabbits (bred at
CSIRO Wildlife and Ecology) were used for animal im-
munisation experiments. The animals were housed and
inoculated under PC2 containment conditions. All experi-
ments were approved by Gungallin Animal Experimenta-
tion Ethics Committee, CSIRO, Australia.
Routes of immunisation
Five groups, each containing eight rabbits, were inocu-
lated as follows: Group 1, intradermal inoculation of 106
plaque-forming units (PFU) of MV-HA; Group 2, same as
for Group 1 except ovulation was induced 12 h prior to
sampling by intravenous injection of 125 international units
of human chorionic gonadotrophin (Intervet Pty., Ltd., Aus-
tralia); Group 3, intranasal inoculation with 106 PFU of
MV-HA; Group 4, intravaginal inoculation with 106 PFU of
MV-HA; Group 5, uninfected controls, four rabbits were
injected with phosphate-buffered saline (PBS) and four rab-
bits were injected with hCG as for Group 2. In Groups 3 and
4, the rabbits were anaesthetised with xylazine (5 mg/kg,
Parnell Laboratory Pty. Ltd., Australia) and Zoletil-100 (15
mg/kg, Virbac Pty., Ltd., Australia) before immunisation.
At 15 and 30 days postinfection four rabbits from each
group were sampled. When rabbits were killed, blood sam-
ples were collected by ear vein or cardiac puncture for
serum preparation. Reproductive tract fluid samples were
collected from the oviduct, uterus, and vagina in two ways.
First, by flushing the lumen with 1 ml sterilised PBS, and
second, free-flowing luminal fluids of these regions were
collected from half of the rabbits in Groups 1, 2, and 5 using
micropuncture method with capillary tubes as described pre-
viously (Sujarit et al., 1990). Reproductive tract tissues were
collected from oviduct (middle ampulla), uterus (middle of
uterine body), cervix (whole cervix), and vagina (1 cm from
cervical conjunction) for preparation of frozen sections.
Time course of mucosal antibody response
Four rabbits were used. Two rabbits were inoculated
intranasally and another two rabbits were inoculated intra-
vaginally with 106 PFU MV-HA. Seventy days postinfec-
tion the rabbits were intravaginally boosted with 5000 HA
units/rabbit of influenza virus in Freud’s incomplete adju-
vant (Sigma). Blood (for serum preparation) and vaginal
washings (with 1 ml PBS) were taken at days 0, 3, 15, 30,
45, 70 after immunisation and days 3, 6, 10 after boosting.
Antibody titres in ovarian follicular fluids
Four rabbits were intradermally immunised with 106
PFU MV-HA and were killed at 15 days postinfection.
Superovulation was induced by intramuscular injection of
150 international units/rabbit of pregnant mare serum go-
nadotrophin (Pregnecol, Agvet Pty, Ltd.) at 72 h before
collection, followed by intravenous injection of 125 inter-
national units/rabbit of hCG at 12 h before collection. The
follicular fluid was collected by puncturing the preovulatory
follicles using microcapillary tubes under a stereo micro-
scope (SZ-PT, Olympus, Japan). A small volume (5 l) of
heparin (2000 u/ml, Sigma) was added to each sample to
prevent coagulation.
Specific antibody and general IgG measurement
ELISA was used to measure HA- or MV-specific IgG,
IgM, and IgA and was as previously described (Kerr and
Jackson, 1995). Twofold serial dilutions in PBS of serum or
ovarian follicular fluids commencing at 1/50 were assayed
for specific IgG, IgM, and IgA titres. Twofold serial dilu-
tions of reproductive tract fluid samples commencing at
1/50 were assayed for specific IgG titres and commencing at
1/5 or 1/3 were assayed for specific IgM and IgA titres. The
antibody titre was determined as the highest dilution giving
an absorbance above 0.1 at 405 nm. Positive and negative
control rabbit sera for HA and myxoma virus were diluted
at 1/100 and used in every assay. ELISA was also used to
measure general IgG titres in serum and reproductive tract
fluids. The samples were similarly diluted in PBS in a
twofold series and 50 l of each dilution was transferred to
a well of microplates for absorption at 37°C for 2 h and then
at 4°C overnight. The plates were washed and blocked with
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3% skim milk in PBS. Goat anti-rabbit IgG conjugated with
HRP (Nordic, The Netherlands) was diluted (1:4000) in 1%
skim milk and 50 l was applied to each well for incubation
at 37°C for 1 h. The colour reaction and plate reading were
as described previously (Kerr and Jackson, 1995). Negative
control was 3% BSA.
Immunofluorescence
Tissue samples were collected and embedded in Tissue-
Tek, O.C.T. Compound (Miles, USA) and then frozen at
70°C. Slides were pretreated with 1% poly-L-lysine
(Sigma) and frozen sections were cut (6 m) and fixed in
formalin-calcium (0.1 M CaCl2 and 1.33 M formaldehyde)
for 5 min followed by cold acetone-chloroform (1:1 vol/vol)
for a further 5 min. Sections were blocked with 3% BSA at
room temperature for 1 h and washed briefly in PBS before
labelling. For single labelling, the primary antibody was
diluted (1:100 for monoclonal antibody to myxoma virus,
clone 3B6E4, Fountain et al., 1997; 1:50 for rat anti- HA
sera, supplied by Dr. Sonja Best, and 1:50 for goat anti-
rabbit IgA sera, Nordic, Netherlands) and applied to each
section for an incubation of 2 h at 37°C. After washes with
PBS, sheep anti-mouse or rat IgG conjugated with FITC
(Silenus) or rabbit anti-goat IgG conjugated with FITC
(Nordic) was applied for 1 h at 37°C. The sections were
washed in PBS and mounted with antifade solution (Mo-
lecular Probes Inc., USA). For double labelling, following
the single labelling described above, sheep anti-mouse IgG
sera (supplied by Dr. Sonja Best, 1:50 dilution) was applied
to block the possible free monoclonal antibody. After
washes in PBS, the second monoclonal antibody to rabbit
MHC class II (SeroTec, 1:20 dilution) was applied for a 2-h
incubation at 37°C. This was followed by PBS washes and
a 1-h incubation with sheep anti-mouse IgG conjugated with
Rhodamine (Silenus, 1:50 dilution) at 37°C. The final wash-
ing and mounting procedures were as above. Each slide was
viewed under confocal microscopy (Bio-Rad, MRC 1000).
Data analysis
Antibody or general IgG titres were transformed into
logarithms and expressed as Log10 titres in the text. Stu-
dent’s t-test was used to test for differences between treated
groups and untreated controls. P  0.05 (two-tailed) was
considered as significant.
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